Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

January 28, 2020

Presentation

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Presenter: BM. Everett BM

August 14, 2015

Presentation

COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease

Presenter: S. Acharjee

July 31, 2015

Presentation CATCH-UP 2015

Cardiac Disease in Pregnancy

Presenter: Jennifer Haythe

April 25, 2015

Presentation CATCH-UP 2015

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Presenter: Silviu Itescu

April 24, 2015

Presentation

Meta-analysis of Trials on Mortality After PCI vs OMT in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia

Presenter: H. Gada

March 24, 2015

Presentation CADECI 2015

Subclinical CV Disease Heart – Brain Integration

Presenter: CADECI 2015

February 19, 2015

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Presenter: 218868|Judith Hochman

May 31, 2013

Presentation TCT 2012

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

Presenter: Bagrat Alekyan

October 22, 2012

Presentation TCT 2012

Can HeartFlow Change the Clinical Management Paradigm for Patients with Coronary Disease?

Presenter: James Min

October 22, 2012

Advertisement

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease

Cardiac Disease in Pregnancy

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Meta-analysis of Trials on Mortality After PCI vs OMT in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia

Subclinical CV Disease Heart – Brain Integration

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

Can HeartFlow Change the Clinical Management Paradigm for Patients with Coronary Disease?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content